Kronborg Mads Brix, Albertsen Andi Eie, Nielsen Jens Cosedis, Mortensen Peter Thomas
Department of Cardiology, Aarhus University Hospital, Skejby, Bendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.
Europace. 2009 Sep;11(9):1177-82. doi: 10.1093/europace/eup202. Epub 2009 Aug 6.
To identify the predictive value of a presumed optimal left ventricular lead positions (LV-Ps) on the long-term clinical outcome in patients with cardiac resynchronization therapy (CRT).
Clinical information was collected from patient files in consecutive patients treated with CRT from 1997 to 2007. A presumed optimal LV-Ps were defined as a position between 2 and 5 o'clock in the short-axis circumference and basal or mid-ventricular in the long axis. Symptomatic response was defined as improvement in NYHA class (>or=1) and echocardiographic response as improvement in left ventricular ejection fraction of >or=5% absolute. We included 567 patients [median age 66 years, 453 (80%) male]. The LV-Ps were optimal in 334 (59%) patients. The hazard ratio for all-cause mortality with an optimal LV-Ps was unadjusted 0.79 (0.59-1.06) and adjusted 0.99 (0.71-1.40). The odds ratio (OR) for symptomatic response with an optimal LV-Ps was unadjusted 1.13 (0.79-1.64) and adjusted 1.05 (0.67-1.64), and the OR for echocardiographic response was unadjusted 1.60 (1.02-2.49) and adjusted 1.42 (0.88-2.31).
A presumed optimal LV-Ps between 2 and 5 o'clock in the short-axis circumference and basal or mid-ventricular in the long axis is not associated with a lower mortality or a better clinical response in patients treated with CRT.
确定假定的最佳左心室电极位置(LV-Ps)对心脏再同步治疗(CRT)患者长期临床结局的预测价值。
收集了1997年至2007年接受CRT治疗的连续患者病历中的临床信息。假定的最佳LV-Ps定义为短轴周长2至5点之间且长轴为基底部或心室中部的位置。症状改善定义为纽约心脏协会(NYHA)心功能分级改善(≥1级),超声心动图改善定义为左心室射血分数绝对提高≥5%。我们纳入了567例患者[中位年龄66岁,453例(80%)为男性]。334例(59%)患者的LV-Ps为最佳位置。最佳LV-Ps的全因死亡率未调整风险比为0.79(0.59 - 1.06),调整后为0.99(0.71 - 1.40)。最佳LV-Ps的症状改善优势比(OR)未调整为1.13(0.79 - 1.64),调整后为1.05(0.67 - 1.64),超声心动图改善的OR未调整为1.60(1.02 - 2.49),调整后为1.42(0.88 - 2.31)。
短轴周长2至5点之间且长轴为基底部或心室中部的假定最佳LV-Ps与接受CRT治疗患者的较低死亡率或更好临床反应无关。